{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:02:12Z","timestamp":1768564932481,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1038\/nrneph.2009.214","type":"journal-article","created":{"date-parts":[[2010,1,29]],"date-time":"2010-01-29T10:11:34Z","timestamp":1264759894000},"page":"96-106","source":"Crossref","is-referenced-by-count":74,"title":["Imaging for the prognosis of autosomal dominant polycystic kidney disease"],"prefix":"10.1038","volume":"6","author":[{"given":"Kyongtae T.","family":"Bae","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jared J.","family":"Grantham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFnrneph2009214_CR1","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1056\/NEJMcp0804458","volume":"359","author":"JJ Grantham","year":"2008","unstructured":"Grantham, J. J. Clinical practice. Autosomal dominant polycystic kidney disease. N. Engl. J. Med. 359, 1477\u20131485 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2009214_CR2","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/ki.1992.195","volume":"41","author":"PA Gabow","year":"1992","unstructured":"Gabow, P. A. et al. Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int. 41, 1311\u20131319 (1992).","journal-title":"Kidney Int."},{"key":"BFnrneph2009214_CR3","doi-asserted-by":"publisher","first-page":"148","DOI":"10.2215\/CJN.00330705","volume":"1","author":"JJ Grantham","year":"2006","unstructured":"Grantham, J. J., Chapman, A. B. & Torres, V. E. Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes. Clin. J. Am. Soc. Nephrol. 1, 148\u2013157 (2006).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2009214_CR4","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1056\/NEJMoa054341","volume":"354","author":"JJ Grantham","year":"2006","unstructured":"Grantham, J. J. et al. Volume progression in polycystic kidney disease. N. Engl. J. Med. 354, 2122\u20132130 (2006).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2009214_CR5","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1681\/ASN.V5122037","volume":"5","author":"S Klahr","year":"1995","unstructured":"Klahr, S. et al. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group. J. Am. Soc. Nephrol. 5, 2037\u20132047 (1995).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2009214_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0272-6386(87)80158-0","volume":"9","author":"JR Gregoire","year":"1987","unstructured":"Gregoire, J. R., Torres, V. E., Holley, K. E. & Farrow, G. M. Renal epithelial hyperplastic and neoplastic proliferation in autosomal dominant polycystic kidney disease. Am. J. Kidney Dis. 9, 27\u201338 (1987).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2009214_CR7","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev.med.60.101707.125712","volume":"60","author":"PC Harris","year":"2009","unstructured":"Harris, P. C. & Torres, V. E. Polycystic kidney disease. Annu. Rev. Med. 60, 321\u2013337 (2009).","journal-title":"Annu. Rev. Med."},{"key":"BFnrneph2009214_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/(SICI)1520-6408(1999)24:3\/4<309::AID-DVG14>3.0.CO;2-5","volume":"24","author":"VH Gattone 2nd","year":"1999","unstructured":"Gattone, V. H. 2nd, Maser, R. L., Tian, C., Rosenberg, J. M. & Branden, M. G. Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease. Dev. Genet. 24, 309\u2013318 (1999).","journal-title":"Dev. Genet."},{"key":"BFnrneph2009214_CR9","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/nm935","volume":"9","author":"VH Gattone 2nd","year":"2003","unstructured":"Gattone, V. H. 2nd, Wang, X., Harris, P. C. & Torres, V. E. Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat. Med. 9, 1323\u20131326 (2003).","journal-title":"Nat. Med."},{"key":"BFnrneph2009214_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nm1004","volume":"10","author":"VE Torres","year":"2004","unstructured":"Torres, V. E. et al. Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease. Nat. Med. 10, 363\u2013364 (2004).","journal-title":"Nat. Med."},{"key":"BFnrneph2009214_CR11","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1681\/ASN.2004121090","volume":"16","author":"X Wang","year":"2005","unstructured":"Wang, X., Gattone, V. 2nd, Harris, P. C. & Torres, V. E. Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat. J. Am. Soc. Nephrol. 16, 846\u2013851 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2009214_CR12","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1681\/ASN.2006030251","volume":"17","author":"S Nagao","year":"2006","unstructured":"Nagao, S. et al. Increased water intake decreases progression of polycystic kidney disease in the PCK rat. J. Am. Soc. Nephrol. 17, 2220\u20132227 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2009214_CR13","unstructured":"TEMPO 3\/4 Trial\u201d Tolvaptan Efficacy and Safety in Management of Polycystic Kidney Disease and Its Outcomes (TEMPO3\/4) ClinicalTrials.gov A service of the U. S. National Institutes of Health [ online ], (2009)."},{"key":"BFnrneph2009214_CR14","unstructured":"Somatostatin in Polycystic Kidney: a Long-term Three Year Follow up Study ClinicalTrials.gov A service of the U. S. National Institutes of Health [ online ], (2009)."},{"key":"BFnrneph2009214_CR15","unstructured":"Octreotide in Severe Polycystic Liver Disease ClinicalTrials.gov A service of the U. S. National Institutes of Health [ online ], (2009)."},{"key":"BFnrneph2009214_CR16","unstructured":"Lanreotide as Treatment of Polycystic Livers (LOCKCYST) ClinicalTrials.gov A service of the U. S. National Institutes of Health [ online ], (2009)."},{"key":"BFnrneph2009214_CR17","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.2215\/CJN.05611207","volume":"3","author":"CL Edelstein","year":"2008","unstructured":"Edelstein, C. L. Mammalian target of rapamycin and caspase inhibitors in polycystic kidney disease. Clin. J. Am. Soc. Nephrol. 3, 1219\u20131226 (2008).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2009214_CR18","first-page":"25","volume":"22","author":"CL Edelstein","year":"2008","unstructured":"Edelstein, C. L. Therapeutic interventions for autosomal dominant polycystic kidney disease. Nephrol. News Issues 22, 25\u201326 (2008).","journal-title":"Nephrol. News Issues"},{"key":"BFnrneph2009214_CR19","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1681\/ASN.2007050626","volume":"19","author":"Q Qian","year":"2008","unstructured":"Qian, Q. et al. Sirolimus reduces polycystic liver volume in ADPKD patients. J. Am. Soc. Nephrol. 19, 631\u2013638 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2009214_CR20","doi-asserted-by":"publisher","first-page":"F1423","DOI":"10.1152\/ajprenal.00275.2007","volume":"293","author":"T Weimbs","year":"2007","unstructured":"Weimbs, T. Polycystic kidney disease and renal injury repair: common pathways, fluid flow, and the function of polycystin-1. Am. J. Physiol. Renal Physiol. 293, F1423\u2013F1432 (2007).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrneph2009214_CR21","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1159\/000104818","volume":"30","author":"M Wu","year":"2007","unstructured":"Wu, M. et al. Everolimus retards cyst growth and preserves kidney function in a rodent model for polycystic kidney disease. Kidney Blood Press. Res. 30, 253\u2013259 (2007).","journal-title":"Kidney Blood Press. Res."},{"key":"BFnrneph2009214_CR22","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.4161\/cc.5.21.3408","volume":"5","author":"T Weimbs","year":"2006","unstructured":"Weimbs, T. Regulation of mTOR by polycystin-1: is polycystic kidney disease a case of futile repair? Cell Cycle 5, 2425\u20132429 (2006).","journal-title":"Cell Cycle"},{"key":"BFnrneph2009214_CR23","unstructured":"Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD) ClinicalTrials.gov A service of the U. S. National Institutes of Health [ online ], (2006)."},{"key":"BFnrneph2009214_CR24","unstructured":"Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and Safety (SIRENA) ClinicalTrials.gov A service of the U. S. National Institutes of Health [ online ], (2007)."},{"key":"BFnrneph2009214_CR25","unstructured":"Sirolimus (Rapamune\u00ae) for Autosomal Dominant Polycystic Kidney Disease (ADPKD) ClinicalTrials.gov A service of the U. S. National Institutes of Health [ online ], (2008)."},{"key":"BFnrneph2009214_CR26","unstructured":"Efficacy, Safety and Tolerability of Everolimus in Preventing End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease ClinicalTrials.gov A service of the U. S. National Institutes of Health [ online ], (2008)."},{"key":"BFnrneph2009214_CR27","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/j.1464-410X.2007.07423.x","volume":"101","author":"PJ Desai","year":"2008","unstructured":"Desai, P. J. et al. Bilateral laparoscopic nephrectomy for significantly enlarged polycystic kidneys: a technique to optimize outcome in the largest of specimens. BJU Int. 101, 1019\u20131023 (2008).","journal-title":"BJU Int."},{"key":"BFnrneph2009214_CR28","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1056\/NEJM199010183231601","volume":"323","author":"PS Parfrey","year":"1990","unstructured":"Parfrey, P. S. et al. The diagnosis and prognosis of autosomal dominant polycystic kidney disease. N. Engl. J. Med. 323, 1085\u20131090 (1990).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2009214_CR29","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/S0140-6736(94)92026-5","volume":"343","author":"D Ravine","year":"1994","unstructured":"Ravine, D. et al. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 343, 824\u2013827 (1994).","journal-title":"Lancet"},{"key":"BFnrneph2009214_CR30","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1148\/radiology.211.3.r99jn19623","volume":"211","author":"J Bakker","year":"1999","unstructured":"Bakker, J. et al. Renal volume measurements: accuracy and repeatability of US compared with that of MR imaging. Radiology 211, 623\u2013628 (1999).","journal-title":"Radiology"},{"key":"BFnrneph2009214_CR31","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1053\/j.ajkd.2005.08.026","volume":"46","author":"WC O'Neill","year":"2005","unstructured":"O'Neill, W. C. et al. Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP). Am. J. Kidney Dis. 46, 1058\u20131064 (2005).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2009214_CR32","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1053\/ajkd.2002.33379","volume":"39","author":"GM Fick-Brosnahan","year":"2002","unstructured":"Fick-Brosnahan, G. M., Belz, M. M., McFann, K. K., Johnson, A. M. & Schrier, R. W. Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: a longitudinal study. Am. J. Kidney Dis. 39, 1127\u20131134 (2002).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2009214_CR33","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1681\/ASN.V1181505","volume":"11","author":"BF King","year":"2000","unstructured":"King, B. F., Reed, J. E., Bergstralh, E. J., Sheedy, P. F. 2nd & Torres, V. E. Quantification and longitudinal trends of kidney, renal cyst, and renal parenchyma volumes in autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 11, 1505\u20131511 (2000).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2009214_CR34","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1046\/j.1523-1755.2000.00433.x","volume":"58","author":"C Sise","year":"2000","unstructured":"Sise, C. et al. Volumetric determination of progression in autosomal dominant polycystic kidney disease by computed tomography. Kidney Int. 58, 2492\u20132501 (2000).","journal-title":"Kidney Int."},{"key":"BFnrneph2009214_CR35","doi-asserted-by":"publisher","first-page":"112","DOI":"10.2215\/CJN.00910306","volume":"2","author":"VE Torres","year":"2007","unstructured":"Torres, V. E. et al. Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease. Clin. J. Am. Soc. Nephrol. 2, 112\u2013120 (2007).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2009214_CR36","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.mric.2009.01.003","volume":"17","author":"JC Weinreb","year":"2009","unstructured":"Weinreb, J. C. & Kuo, P. H. Nephrogenic systemic fibrosis. Magn. Reson. Imaging Clin. N. Am. 17, 159\u2013167 (2009).","journal-title":"Magn. Reson. Imaging Clin. N. Am."},{"key":"BFnrneph2009214_CR37","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1148\/radiol.2213010178","volume":"221","author":"AB Nascimento","year":"2001","unstructured":"Nascimento, A. B. et al. Rapid MR imaging detection of renal cysts: age-based standards. Radiology 221, 628\u2013632 (2001).","journal-title":"Radiology"},{"key":"BFnrneph2009214_CR38","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1097\/00004728-200007000-00019","volume":"24","author":"KT Bae","year":"2000","unstructured":"Bae, K. T., Commean, P. K. & Lee, J. Volumetric measurement of renal cysts and parenchyma using MRI: phantoms and patients with polycystic kidney disease. J. Comput. Assist. Tomogr. 24, 614\u2013619 (2000).","journal-title":"J. Comput. Assist. Tomogr."},{"key":"BFnrneph2009214_CR39","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1046\/j.1523-1755.2003.00185.x","volume":"64","author":"AB Chapman","year":"2003","unstructured":"Chapman, A. B. et al. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort. Kidney Int. 64, 1035\u20131045 (2003).","journal-title":"Kidney Int."},{"key":"BFnrneph2009214_CR40","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2215\/CJN.00080605","volume":"1","author":"KT Bae","year":"2006","unstructured":"Bae, K. T. et al. Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort. Clin. J. Am. Soc. Nephrol. 1, 64\u201369 (2006).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2009214_CR41","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/BF02927815","volume":"3","author":"HS Thomsen","year":"1981","unstructured":"Thomsen, H. S., Madsen, J. K., Thaysen, J. H. & Damgaard-Petersen, K. Volume of polycystic kidneys during reduction of renal function. Urol. Radiol. 3, 85\u201389 (1981).","journal-title":"Urol. Radiol."},{"key":"BFnrneph2009214_CR42","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0272-6386(99)70387-2","volume":"34","author":"G Fick-Brosnahan","year":"1999","unstructured":"Fick-Brosnahan, G., Johnson, A. M., Strain, J. D. & Gabow, P. A. Renal asymmetry in children with autosomal dominant polycystic kidney disease. Am. J. Kidney Dis. 34, 639\u2013645 (1999).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2009214_CR43","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1046\/j.1523-1755.2001.0590051654.x","volume":"59","author":"GM Fick-Brosnahan","year":"2001","unstructured":"Fick-Brosnahan, G. M., Tran, Z. V., Johnson, A. M., Strain, J. D. & Gabow, P. A. Progression of autosomal-dominant polycystic kidney disease in children. Kidney Int. 59, 1654\u20131662 (2001).","journal-title":"Kidney Int."},{"key":"BFnrneph2009214_CR44","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1523-1755.2005.00395.x","volume":"68","author":"P Ruggenenti","year":"2005","unstructured":"Ruggenenti, P. et al. Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease. Kidney Int. 68, 206\u2013216 (2005).","journal-title":"Kidney Int."},{"key":"BFnrneph2009214_CR45","doi-asserted-by":"publisher","first-page":"820","DOI":"10.2215\/CJN.02810608","volume":"4","author":"MA Cadnapaphornchai","year":"2009","unstructured":"Cadnapaphornchai, M. A., McFann, K., Strain, J. D., Masoumi, A. & Schrier, R. W. Prospective change in renal volume and function in children with ADPKD. Clin. J. Am. Soc. Nephrol. 4, 820\u2013829 (2009).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2009214_CR46","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/ki.2008.558","volume":"75","author":"AD Kistler","year":"2009","unstructured":"Kistler, A. D. et al. Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months. Kidney Int. 75, 235\u2013241 (2009).","journal-title":"Kidney Int."},{"key":"BFnrneph2009214_CR47","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2215\/CJN.03750708","volume":"4","author":"KT Bae","year":"2009","unstructured":"Bae, K. T. et al. MRI-based kidney volume measurements in ADPKD: reliability and effect of gadolinium enhancement. Clin. J. Am. Soc. Nephrol. 4, 719\u2013725 (2009).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2009214_CR48","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1681\/ASN.2006080835","volume":"17","author":"PC Harris","year":"2006","unstructured":"Harris, P. C. et al. Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 17, 3013\u20133019 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2009214_CR49","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/sj.ki.5002624","volume":"73","author":"JJ Grantham","year":"2008","unstructured":"Grantham, J. J. et al. Determinants of renal volume in autosomal-dominant polycystic kidney disease. Kidney Int. 73, 108\u2013116 (2008).","journal-title":"Kidney Int."},{"key":"BFnrneph2009214_CR50","doi-asserted-by":"publisher","first-page":"c173","DOI":"10.1159\/000092915","volume":"103","author":"YR Lee","year":"2006","unstructured":"Lee, Y. R. & Lee, K. B. Reliability of magnetic resonance imaging for measuring the volumetric indices in autosomal-dominant polycystic kidney disease: correlation with hypertension and renal function. Nephron Clin. Pract. 103, c173\u2013c180 (2006).","journal-title":"Nephron Clin. Pract."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2009.214.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2009.214","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2009.214.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:32:12Z","timestamp":1684470732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2009.214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["BFnrneph2009214"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2009.214","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}